Sichuan Biokin Pharmaceutical Co.,Ltd. (SHA:688506)

Market Cap	100.77B -29.0%
Revenue (ttm)	2.55B +14.5%
Net Income	-1.26B
EPS	-3.07
Shares Out	412.87M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,907,409
Open	237.14
Previous Close	240.77
Day's Range	237.14 - 253.00
52-Week Range	200.10 - 404.00
Beta	-0.05
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 31, 2026

About SHA:688506

Sichuan Biokin Pharmaceutical Co.,Ltd. engages in the research and development, manufacture, and sale of biomedicine in the fields of antibody drug conjugate, guidance navigation and control, and antibody radionuclide conjugate in China and internationally. It offers anesthesia, parenteral nutrition, anti-infectives, pediatrics, and traditional Chinese medicines. The company was founded in 1996 and is headquartered in Chengdu, China.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1996
• Employees: 3,434
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 688506

Financial Performance

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Oct 30, 2026

Data Sources Report a data error